Solventum Change in Accounts Receivable 2023-2025 | SOLV
Solventum annual/quarterly change in accounts receivable history and growth rate from 2023 to 2025. Change in accounts receivable can be defined as the increase or decrease in accounts receivable for the given period.
- Solventum change in accounts receivable for the quarter ending March 31, 2025 was $6M, a 92.31% decline year-over-year.
- Solventum change in accounts receivable for the twelve months ending March 31, 2025 was $133M, a 226.67% decline year-over-year.
- Solventum annual change in accounts receivable for 2024 was $0.043B, a 133.33% decline from 2023.
- Solventum annual change in accounts receivable for 2023 was $-0.129B, a 303.13% increase from 2022.
- Solventum annual change in accounts receivable for 2022 was $-0.032B, a 0% decline from .
| Solventum Annual Change in Accounts Receivable (Millions of US $) |
|
|---|---|
| 2024 | $43 |
| 2023 | $-129 |
| 2022 | $-32 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $12.531B | $8.254B |
| Solventum is an independent healthcare company. Its business segment includes Medical Surgical, Dental Solutions, Health Information Systems and Purification and Filtration. Solventum is based in ST. PAUL, Minn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.523B | 26.43 |
| CVS Health (CVS) | United States | $80.437B | 10.00 |
| Elevance Health (ELV) | United States | $62.242B | 8.37 |
| Cencora (COR) | United States | $56.664B | 19.71 |
| DiDi Global (DIDIY) | China | $24.380B | 25.90 |
| Labcorp Holdings (LH) | United States | $21.895B | 17.40 |
| Natera (NTRA) | United States | $19.133B | 0.00 |
| BioMerieux (BMXMF) | France | $17.067B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.105B | 0.00 |
| ICON (ICLR) | Ireland | $13.404B | 12.90 |
| CochLear (CHEOY) | Australia | $13.242B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.257B | 32.44 |
| Viatris (VTRS) | United States | $10.540B | 3.62 |
| Revvity (RVTY) | United States | $10.453B | 18.14 |
| Sonic Healthcare (SKHHY) | Australia | $8.877B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.226B | 16.12 |
| Avantor (AVTR) | United States | $7.935B | 11.64 |
| HealthEquity (HQY) | United States | $7.870B | 34.47 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.708B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $5.109B | 34.38 |
| Amplifon S.p.A (AMFPF) | Italy | $3.890B | 21.30 |
| BrightSpring Health Services (BTSG) | United States | $3.516B | 26.82 |
| Sotera Health (SHC) | United States | $3.176B | 18.05 |
| GeneDx Holdings (WGS) | United States | $3.043B | 70.16 |
| Surgery Partners (SGRY) | United States | $2.837B | 35.71 |
| Alignment Healthcare (ALHC) | United States | $2.656B | 0.00 |
| Concentras Parent (CON) | United States | $2.540B | 14.68 |
| Organon (OGN) | United States | $2.184B | 2.38 |
| Progyny (PGNY) | United States | $1.990B | 43.81 |
| Premier (PINC) | United States | $1.788B | 13.57 |
| PACS (PACS) | United States | $1.740B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.568B | 31.36 |
| Ardent Health (ARDT) | United States | $1.523B | 5.88 |
| Establishment Labs Holdings (ESTA) | $1.273B | 0.00 | |
| Teladoc Health (TDOC) | United States | $1.230B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.110B | 7.51 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.831B | 285.00 |
| CareDx (CDNA) | United States | $0.715B | 11.17 |
| AMN Healthcare Services Inc (AMN) | United States | $0.670B | 6.27 |
| Performant Healthcare (PHLT) | United States | $0.597B | 0.00 |
| Embecta (EMBC) | United States | $0.580B | 3.91 |
| LifeMD (LFMD) | United States | $0.538B | 0.00 |
| Nutex Health (NUTX) | United States | $0.506B | 7.67 |
| So-Young (SY) | China | $0.499B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.466B | 10.50 |
| InnovAge Holding (INNV) | United States | $0.466B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.457B | 0.00 |
| SBC Medicals (SBC) | United States | $0.453B | 0.00 |
| Omada Health (OMDA) | $0.446B | 0.00 | |
| COMPASS Pathways (CMPS) | United Kingdom | $0.430B | 0.00 |
| Agilon Health (AGL) | United States | $0.365B | 0.00 |
| Oncology Institute (TOI) | United States | $0.353B | 0.00 |
| Enhabit (EHAB) | United States | $0.339B | 27.88 |
| Beauty Health (SKIN) | United States | $0.208B | 0.00 |
| DocGo (DCGO) | United States | $0.143B | 23.33 |
| Ascend Wellness Holdings (AAWH) | United States | $0.094B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.092B | 0.00 |
| Biodesix (BDSX) | United States | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| KindlyMD (NAKA) | United States | $0.053B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.052B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.040B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.038B | 0.00 |
| ModivCare (MODV) | United States | $0.037B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.014B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |